# Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction

Study · id `cardio:ct-nct02435797` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02435797](<https://clinicaltrials.gov/study/NCT02435797>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02435797

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02435797. Randomized; single masking; primary purpose prevention. Start 2015-04 (registry gives no type); primary completion 2015-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02435797, source copy `cardio:ctgov-nct02435797-2015-05-06`, retrieved 2026-10-26)
- Start date: 2015-04 (registry gives no type) (ClinicalTrials.gov record NCT02435797, source copy `cardio:ctgov-nct02435797-2015-05-06`, retrieved 2026-10-26)
- Primary completion: 2015-08 (anticipated) (ClinicalTrials.gov record NCT02435797, source copy `cardio:ctgov-nct02435797-2015-05-06`, retrieved 2026-10-26)
- Completion: 2016-10 (anticipated) (ClinicalTrials.gov record NCT02435797, source copy `cardio:ctgov-nct02435797-2015-05-06`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02435797, source copy `cardio:ctgov-nct02435797-2015-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02435797-2015-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
- Condition: Coronary Heart Disease
- Intervention (Drug): Nicorandil
- Intervention (Drug): normal saline
- Lead sponsor: Xuzhou Central Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (`cardio:pubmed-29891250`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 15dc62252d33a58fe502c667b47224659b751e14b8b54061e7fc5f9d9ed12451
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
